Patients
AML
AML
Eligible patients, presented with histologically confirmed AML by WHO criteria [All patients provided written informed consent prior to enrolment. The study was approved by the leading ethics committee of the University Hospital Tübingen (184/2016AMG1), local ethics committees and the Paul Ehrlich Institute (2893). The trial was registered on clinicaltrials.gov (NCT02789254) and EudraCT number 2016-000236-17.